| Patient | Elisabeth of Austria |
|---|---|
| Date of birth | 1837-12-24 |
| Identifiers | MRN HR-NI030-SYN-TD; SSN (made up) 000-30-5817 |
| Document date | 1894-03-03 |
| Author | Adelheid Marchetti-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-week review of anorexia nervosa: weight, vital signs, electrolytes, bone density and depression. [S]
Empress Elisabeth returns three weeks after her consultation. She has had four CBT-E sessions, two in person and two by video, has seen the dietitian twice, and had a video review with Dr. Haddad-Lindström last week; her plan is now about 2,200 kcal a day. She took the phosphorus tablets for three weeks and finished thiamine. The weekly blood tests were drawn at laboratories where she stayed and were reported to the clinic as normal. She has walked about an hour a day and stopped weighing herself at home, which she found very hard. The dizziness on standing has nearly gone and the ankle swelling is less. Her mood is still low and she thinks often of her son; she has had passive thoughts of death on two days, with no intent or plan. [S]
| Element | Detail |
|---|---|
| Treatment | Four CBT-E sessions; dietitian twice; about 2,200 kcal a day |
| Blood tests | Weekly tests drawn where she stayed; normal |
| Exercise | About an hour of walking a day |
| Symptoms | Dizziness nearly gone; ankle swelling less |
| Safety | Passive thoughts on two days; no intent or plan |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Energy a little better; still cold |
| Cardiovascular | Negative | No palpitations; ankle swelling less |
| Gastrointestinal | Positive | Fullness after meals, easing |
| Musculoskeletal | Negative | No bone pain or fractures |
| Psychiatric | Positive | Low mood and grief; PHQ-9 14 |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal plan | once daily for 14 days | Oral route | 1894-02-03 to 1894-02-17 | completed | S |
| Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily | once daily | Oral route | 1894-02-03 | active | S |
| Phosphorus 250 mg tablet (potassium and sodium phosphates), one by mouth twice daily with meals for three weeks | twice daily with meals | Oral route | 1894-02-10 to 1894-03-03 | completed | S |
| Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a meal | once daily with a meal | Oral route | 1894-03-03 | active | S |
| Sertraline 25 mg tablet, one by mouth each morning for two weeks | once daily in the morning | Oral route | 1894-03-03 to 1894-03-17 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1894-03-03 | Body height | 172 | cm | S |
| 1894-03-03 | Body weight | 49.6 | kg | S |
| 1894-03-03 | Body mass index (BMI) [Ratio] | 16.8 | kg/m2 | S |
| 1894-03-03 | Systolic blood pressure | 100 | mm[Hg] | S |
| 1894-03-03 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1894-03-03 | Heart rate | 56 | /min | S |
| 1894-03-03 | Respiratory rate | 14 | /min | S |
| 1894-03-03 | Body temperature | 36.2 | Cel | S |
| 1894-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1894-03-03 | Hemoglobin [Mass/volume] in Blood | 11.9 | g/dL | 12-15.5 g/dL | Low | S |
| 1894-03-03 | Leukocytes [#/volume] in Blood by Automated count | 3.9 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 1894-03-03 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1894-03-03 | Potassium [Moles/volume] in Serum or Plasma | 3.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1894-03-03 | Glucose [Mass/volume] in Serum or Plasma | 80 | mg/dL | 70-99 mg/dL | Normal | S |
| 1894-03-03 | Magnesium [Mass/volume] in Serum or Plasma | 1.9 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1894-03-03 | Phosphate [Mass/volume] in Serum or Plasma | 3.2 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1894-03-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 7-35 U/L | High | S |
| 1894-03-03 | Q-T interval corrected | 436 | ms | Above 460 ms is prolonged in women | Normal | S |
| 1894-03-03 | DXA Lumbar spine [T-score] Bone density | -2.1 | {T-score} | -1.0 or higher is normal; -2.5 or lower is osteoporosis | Low | S |
| 1894-03-03 | DXA Femur [T-score] Bone density | -1.8 | {T-score} | -1.0 or higher is normal; -2.5 or lower is osteoporosis | Low | S |
| 1894-03-03 | Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment | 6.8 | % | S | ||
| 1894-03-03 | Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment | 1.2 | % | S | ||
| 1894-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 14 | {score} | S |
Vital signs recorded on 1894-03-03; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin; weight 49.6 kg, BMI 16.8; temperature 36.2 C |
| Cardiovascular | Lying blood pressure 102/66, pulse 54; standing 98/64, pulse 64; regular rhythm; trace ankle edema |
| Musculoskeletal | Standing height 172 cm; no spinal tenderness |
| Psychiatric | Mood low, affect constricted, tearful when speaking of her son; no intent or plan to harm herself |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requested | resolved | confirmed | R63.4 | S — Synthetic presenting problem anchored to her documented restrictive eating, low weight and swelling; superseded by the diagnosis at the consultation. |
| Anorexia nervosa, restricting type, moderate (DSM-5-TR), with compulsive exercise and frequent self-weighing, beginning in early adulthood; complicated at diagnosis by sinus bradycardia, orthostatic dizziness, ankle edema, mild anemia and leukopenia, low glucose, raised ALT and low phosphate after refeeding began | active | confirmed | F50.011 | S — Synthetic modern diagnosis made at the consultation, linked to her documented restrictive eating and exercise and to the retrospective diagnosis of anorexia nervosa (R). |
| Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intake | active | confirmed | F33.1 | S — Synthetic modern diagnosis linked to her documented mourning and ever-deepening depressions; not a claim that she was so diagnosed. |
| Low bone mass (osteopenia) of the lumbar spine and hip after decades of low weight: lumbar spine T-score -2.1, femoral neck T-score -1.8; FRAX 10-year probabilities 6.8% for a major osteoporotic fracture and 1.2% for hip fracture; no fractures | active | confirmed | M85.80 | S — Synthetic modern finding on DXA; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Weight and BMI (open weighing in the consulting room) | Weekly at first, then every visit | Completed today | 49.6 kg, BMI 16.8; up 2.2 kg since intake; weekly weights at CBT-E sessions |
| Examination | Orthostatic pulse and blood pressure, and temperature | Every visit | Completed today | Pulse 54 lying, 64 standing; blood pressure 102/66 lying, 98/64 standing; temperature 36.2 C; orthostatic changes resolved |
| Laboratory | Sodium, potassium, phosphate, magnesium and glucose | Baseline; three to four days after nutrition starts; weekly for the first weeks; then at each visit while underweight | Completed today | Weekly tests normal; today sodium 138, potassium 3.9 mmol/L, phosphate 3.2 mg/dL, magnesium 1.9 mg/dL, glucose 80 mg/dL |
| Laboratory | Blood count and liver enzymes | Baseline; repeat when abnormal | Completed today | Hemoglobin 11.9 g/dL, white cells 3.9 x10^3/uL, ALT 38 U/L, all improving |
| Imaging | ECG for bradycardia and QTc | Baseline; repeat with abnormal electrolytes and before QT-prolonging drugs | Completed today | Sinus rhythm 56, QTc 436 ms, before sertraline |
| Imaging | DXA of the spine and hip | Once for a postmenopausal woman with long-standing low weight; then every two years | Completed today | Lumbar spine T-score -2.1, femoral neck -1.8 |
| Survey | FRAX 10-year fracture probability | With each DXA and when risk factors change | Completed today | 6.8% major osteoporotic, 1.2% hip |
| Self-management | Calcium and vitamin D intake | Every visit | Completed today | Calcium supplement started; vitamin D continued |
| Examination | Refeeding edema and signs of heart failure | Every visit | Completed today | Trace ankle edema |
| Self-management | Exercise and compulsive activity | Every visit | Completed today | About an hour of walking a day; no gymnastics |
| Self-management | Multidisciplinary treatment: CBT-E attendance, dietitian, psychiatry | Weekly therapy; dietitian every two weeks | Completed today | Four CBT-E sessions and two dietitian visits attended |
| Survey | PHQ-9 | At least monthly during acute treatment | Completed today | 14, from 16 |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | Passive thoughts of death on two days; no intent, plan or preparatory behavior; PHQ-9 item 9 scored 1. Safety plan reviewed |
| Medication safety | SSRI tolerability check two weeks after starting | 2 weeks after starting and after each dose change | Ordered | Nurse telephone check booked for two weeks from today |
Goal progress:
Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Eating Disorders: A Guide to Medical Care (AED Medical Care Standards Guide), 4th edition (2021); ASPEN Consensus Recommendations for Refeeding Syndrome (2020); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders and osteoporosis monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Osteoporosis to Prevent Fractures: Screening (2025)
Follow-up: Nurse telephone check in two weeks. Preventive visit in three weeks. Review in eight weeks. Next scheduled visit 1894-03-24: periodic adult preventive visit. [S]